anti-VEGF anticalin PRS-050-PEG40
Term · Oncology and biomedicine · MLC-T-ONC-011170
A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth.
| Identifier | MLC-T-ONC-011170 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011170",
"term": "anti-VEGF anticalin PRS-050-PEG40",
"field": "Oncology and biomedicine",
"definition": "A pegylated, proprietary lipocalin that targets human vascular endothelial growth factor (VEGF), with potential antineoplastic activity. Pegylated anti-VEGF anticalin PRS-050 specifically targets and binds to VEGF receptor 2 (VEGFR2 or KDR), thereby preventing its activity. This may inhibit angiogenesis and eventually reduce tumor cell growth.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-vegf-anticalin-prs-050-peg40/"
}
Record 2,320 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.